|
1
|
Lancet T: Lung cancer: Some progress, but
still a lot more to do. Lancet. 394:18802019. View Article : Google Scholar
|
|
2
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bordoloi D, Banik K, Padmavathi G,
Vikkurthi R, Harsha C, Roy NK, Singh AK, Monisha J, Wang H, Kumar
AP and Kunnumakkara AB: TIPE2 induced the proliferation, survival,
and migration of lung cancer cells through modulation of
Akt/mTOR/NF-κB signaling cascade. Biomolecules. 9:8362019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cohen JD, Li L, Wang Y, Thoburn C, Afsari
B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, et al:
Detection and localization of surgically resectable cancers with a
multi-analyte blood test. Science. 359:926–930. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Didkowska J, Wojciechowska U, Mańczuk M
and Łobaszewski J: Lung cancer epidemiology: Contemporary and
future challenges worldwide. Ann Transl Med. 4:1502016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martin P and Leighl NB: Review of the use
of pretest probability for molecular testing in non-small cell lung
cancer and overview of new mutations that may affect clinical
practice. Ther Adv Med Oncol. 9:405–414. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Garmendia I, Pajares MJ, Hermida-Prado F,
Ajona D, Bértolo C, Sainz C, Lavín A, Remírez AB, Valencia K,
Moreno H, et al: YES1 drives lung cancer growth and progression and
predicts sensitivity to dasatinib. Am J Respir Crit Care Med.
200:888–899. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
St Croix B, Rago C, Velculescu V, Traverso
G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C,
Vogelstein B and Kinzler KW: Genes expressed in human tumor
endothelium. Science. 289:1197–1202. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cao C, Wang Z, Huang L, Bai L, Wang Y,
Liang Y, Dou C and Wang L: Down-regulation of tumor endothelial
marker 8 suppresses cell proliferation mediated by ERK1/2 activity.
Sci Rep. 6:234192016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gong Q, Liu C, Wang C, Zhuang L, Zhang L
and Wang X: Effect of silencing TEM8 gene on proliferation,
apoptosis, migration and invasion of XWLC-05 lung cancer cells. Mol
Med Rep. 17:911–917. 2018.PubMed/NCBI
|
|
12
|
Koo HM, VanBrocklin M, McWilliams MJ,
Leppla SH, Duesbery NS and Vande Woude GF: Apoptosis and
melanogenesis in human melanoma cells induced by anthrax lethal
factor inactivation of mitogen-activated protein kinase kinase.
Proc Natl Acad Sci USA. 99:3052–3057. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Byrd TT, Fousek K, Pignata A, Szot C,
Samaha H, Seaman S, Dobrolecki L, Salsman VS, Oo HZ, Bielamowicz K,
et al: TEM8/ANTXR1-Specific CAR T cells as a targeted therapy for
triple-negative breast cancer. Cancer Res. 78:489–500. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fernando S and Fletcher BS: Targeting
tumor endothelial marker 8 in the tumor vasculature of colorectal
carcinomas in mice. Cancer Res. 69:5126–5132. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chaudhary A, Hilton MB, Seaman S, Haines
DC, Stevenson S, Lemotte PK, Tschantz WR, Zhang XM, Saha S, Fleming
T and St Croix B: TEM8/ANTXR1 blockade inhibits pathological
angiogenesis and potentiates tumoricidal responses against multiple
cancer types. Cancer Cell. 21:212–226. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan FC, Wang QQ, Ruan YH, Ma LJ, Jia JT
and Jin KW: Establishment and biological characteristics of lung
cancer cell line XWLC-05. Ai Zheng. 26:21–25. 2007.(In Chinese).
PubMed/NCBI
|
|
17
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hurwitz H, Fehrenbacher L, Novotny W,
Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S,
Holmgren E, et al: Bevacizumab plus irinotecan, fluorouracil, and
leucovorin for metastatic colorectal cancer. N Engl J Med.
350:2335–2342. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Verheul HM and Pinedo HM: Possible
molecular mechanisms involved in the toxicity of angiogenesis
inhibition. Nat Rev Cancer. 7:475–485. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen HX and Cleck JN: Adverse effects of
anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol.
6:465–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Weidner N: Current pathologic methods for
measuring intratumoral microvessel density within breast carcinoma
and other solid tumors. Breast Cancer Res Treat. 36:169–180. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hernandez JL, Padilla L, Dakhel S, Coll T,
Hervas R, Adan J, Masa M, Mitjans F, Martinez JM, Coma S, et al:
Therapeutic targeting of tumor growth and angiogenesis with a novel
Anti-S100A4 monoclonal antibody. PLoS One. 8:e724802013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Craig M, Ying C and Loberg RD:
Co-inoculation of prostate cancer cells with U937 enhances tumor
growth and angiogenesis in vivo. J Cell Biochem. 103:1–8. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu Z, Ding L, Hong H, Hoggard J, Lu Q and
Chen YH: Claudin-7 inhibits human lung cancer cell migration and
invasion through ERK/MAPK signaling pathway. Exp Cell Res.
317:1935–1946. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kerbel RS: Tumor angiogenesis. N Engl J
Med. 358:2039–2049. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li R, Liu Y, Wang T, Tang J, Xie L, Yao Z,
Li K, Liao Y, Zhou L, Geng Z, et al: The characteristics of lung
cancer in Xuanwei County: A review of differentially expressed
genes and noncoding RNAs on cell proliferation and migration.
Biomed Pharmacother. 119:1093122019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jinnin M, Medici D, Park L, Limaye N, Liu
Y, Boscolo E, Bischoff J, Vikkula M, Boye E and Olsen BR:
Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2
signaling in infantile hemangioma. Nat Med. 14:1236–1246. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carson-Walter EB, Watkins DN, Nanda A,
Vogelstein B, Kinzler KW and St Croix B: Cell surface tumor
endothelial markers are conserved in mice and humans. Cancer Res.
61:6649–6655. 2001.PubMed/NCBI
|
|
30
|
Nanda A, Carson-Walter EB, Seaman S,
Barber TD, Stampfl J, Singh S, Vogelstein B, Kinzler KW and St
Croix B: TEM8 interacts with the cleaved C5 domain of collagen
alpha 3(VI). Cancer Res. 64:817–820. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rmali KA, Watkins G, Harrison G, Parr C,
Puntis MC and Jiang WG: Tumour endothelial marker 8 (TEM-8) in
human colon cancer and its association with tumour progression. Eur
J Surg Oncol. 30:948–953. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen D, Bhat-Nakshatri P, Goswami C, Badve
S and Nakshatri H: ANTXR1, a stem cell-enriched functional
biomarker, connects collagen signaling to cancer stem-like cells
and metastasis in breast cancer. Cancer Res. 73:5821–5833. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Popravka ES, Dyatlova AS, Lin'kova NS,
Krylova YS, Polyakova VO and Kvetnoi IM: Role of LIF Cytokine and
CD34 angiogenesis marker in non-developing pregnancy. Bull Exp Biol
Med. 163:772–776. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vieira SC, Silva BB, Pinto GA, Vassallo J,
Moraes NG, Santana JO, Santos LG, Carvasan GA and Zeferino LC: CD34
as a marker for evaluating angiogenesis in cervical cancer. Pathol
Res Pract. 201:313–318. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tanaka F, Otake Y, Yanagihara K, Kawano Y,
Miyahara R, Li M, Ishikawa S and Wada H: Correlation between
apoptotic index and angiogenesis in non-small cell lung cancer:
Comparison between CD105 and CD34 as a marker of angiogenesis. Lung
Cancer. 39:289–296. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ceyran AB, Şenol S, Güzelmeriç F, Tunçer
E, Tongut A, Özbek B, Şavluk Ö, Aydın A and Ceyran H: Effects of
hypoxia and its relationship with apoptosis, stem cells, and
angiogenesis on the thymus of children with congenital heart
defects: A morphological and immunohistochemical study. Int J Clin
Exp Pathol. 8:8038–8047. 2015.PubMed/NCBI
|
|
37
|
Opoku-Darko M, Yuen C, Gratton K, Sampson
E and Bathe OF: Tumor endothelial marker 8 overexpression in breast
cancer cells enhances tumor growth and metastasis. Cancer Invest.
29:676–682. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Heigener DF, Gandara DR and Reck M:
Targeting of MEK in lung cancer therapeutics. Lancet Respir Med.
3:319–327. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim E, Youn H, Kwon T, Son B, Kang J, Yang
HJ, Seong KM, Kim W and Youn B: PAK1 tyrosine phosphorylation is
required to induce epithelial-mesenchymal transition and
radioresistance in lung cancer cells. Cancer Res. 74:5520–5531.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chang CH, Li JR, Shu KH, Fu YC and Wu MJ:
Hydronephrotic urine in the obstructed kidney promotes urothelial
carcinoma cell proliferation, migration, invasion through the
activation of mTORC2-AKT and ERK signaling pathways. PLoS One.
8:e743002013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Koyama T, Ogawara K, Kasamatsu A, Okamoto
A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H
and Uzawa K: ANGPTL3 is a novel biomarker as it activates ERK/MAPK
pathway in oral cancer. Cancer Med. 4:759–769. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Galante JM, Mortenson MM, Bowles TL,
Virudachalam S and Bold RJ: ERK/BCL-2 pathway in the resistance of
pancreatic cancer to anoikis. J Surg Res. 152:18–25. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lariche N, Lahouel M, Benguedouar L and
Zellagui A: Ferulenol, a sesquiterpene coumarin, induce apoptosis
via mitochondrial dysregulation in lung cancer induced by
Benzo[a]pyrene: Involvement of Bcl2 protein. Anticancer Agents Med
Chem. 17:1357–1362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Beider K, Begin M, Abraham M, Wald H,
Weiss ID, Wald O, Pikarsky E, Zeira E, Eizenberg O, Galun E, et al:
CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple
myeloma tumor growth. Exp Hematol. 39:282–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Boucher MJ, Morisset J, Vachon PH, Reed
JC, Lainé J and Rivard N: MEK/ERK signaling pathway regulates the
expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of
human pancreatic cancer cells. J Cell Biochem. 79:355–369. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chang GC, Hsu SL, Tsai JR, Wu WJ, Chen CY
and Sheu GT: Extracellular signal-regulated kinase activation and
Bcl-2 downregulation mediate apoptosis after gemcitabine treatment
partly via a p53-independent pathway. Eur J Pharmacol. 502:169–183.
2004. View Article : Google Scholar : PubMed/NCBI
|
